Although further investigations are needed to elucidate the underlying molecular mechanisms through which SIRT1 regulates HD in mice, the positive effects observed with SRT2104 provide compelling evidence for the potential of SIRT1 activation as a novel therapeutic strategy for the management of HD. Here, SIRT1 is linked to Huntington disease.